Clinical Guide: The ACE-III Assessment
Overview
The Addenbrooke's Cognitive Examination III (ACE-III) is a comprehensive cognitive screening tool designed to detect cognitive impairment and aid in the differential diagnosis of dementia subtypes. It is an evolution of the ACE-R, refined to improve sensitivity and specificity.
Unlike shorter screens like the MMSE or Mini-Cog, the ACE-III provides a granular breakdown of five cognitive domains, making it particularly useful for distinguishing Alzheimer's Disease (AD) from Frontotemporal Dementia (FTD).
Domain Breakdown
- Attention (18 points): Evaluates orientation, registration, and concentration. The "Serial 7s" task is a key stress test for working memory and sustained attention. Poor performance here is often seen in delirium or vascular cognitive impairment.
- Memory (26 points): Assesses anterograde memory (learning new information) and retrograde memory (semantic knowledge). A classic Alzheimer’s profile often involves poor delayed recall but relatively preserved recognition or semantic memory in early stages.
-
Fluency (14 points): Measures executive function via verbal generation.
Phonemic Fluency (P-words): Relies on frontal lobe function.
Semantic Fluency (Animals): Relies on temporal lobe semantic storage.
Clinical Tip: In Alzheimer's, semantic fluency is often worse than phonemic fluency. In FTD (behavioral variant), phonemic fluency may be disproportionately affected. - Language (26 points): A broad assessment covering comprehension, repetition, naming, reading, and writing. This section is vital for identifying Primary Progressive Aphasia (PPA).
- Visuospatial (16 points): Tests constructional praxis and spatial abilities. Deficits in the clock drawing test or cube copy can indicate parietal lobe dysfunction, common in early Alzheimer's or Lewy Body Dementia.
Scoring & Interpretation
The maximum score is 100. Interpretation should always account for the patient's age, education level, and premorbid functioning.
| Score Range | Clinical Implication |
|---|---|
| 88 - 100 | Normal Range. Cognitive impairment is unlikely, though very high-functioning individuals might still harbor early pathology. |
| 83 - 87 | Inconclusive / Mild. Falls in the borderline range. Suggests possible Mild Cognitive Impairment (MCI). Longitudinal monitoring recommended. |
| < 83 | Impairment Likely. Highly sensitive for dementia. Sensitivity = 1.0; Specificity = 0.96 for detecting dementia syndromes. |
VLAD (Very Light Analysis of Dementia)
Researchers often compare the ratio of VLAD (Fluency + Language) to Memory/Visuospatial scores to help distinguish between FTD (Frontotemporal) and AD (Alzheimer's) pathology. However, the ACE-III total score remains the primary metric for general screening.
Administration Guidelines
- Ensure the patient has their glasses and hearing aids if required.
- For the "Registration" task (Lemon, Key, Ball), ensure the patient repeats them distinctly before moving on, but score only the first attempt.
- For "Fluency", do not allow the patient to use proper nouns (e.g., "Paris" for P-words) or repeat words with different endings (e.g., "Pay, Paying").
- If a patient cannot write due to physical disability (e.g., hemiparesis), the score should be pro-rated or noted as a limitation.